| Product Name | MF | CAS | Details |
|---|
| A-1293102 | 1565759-96-7 | Details |
| Topoisomerase II inhibitor 15 | 451516-79-3 | Details |
| AMPA receptor modulator-5 | 2034182-22-2 | Details |
| CDK9-IN-23 | C22H25ClN4O3 | 2761572-96-5 | Details |
| KRAS G12D modulator-1 | 2883034-05-5 | Details |
| CDD-1845 | 2894104-50-6 | Details |
| Syk-IN-8 | 2568963-01-7 | Details |
| JAK1-IN-11 | 2427608-43-1 | Details |
| PROTAC KRAS G12C degrader-3 | 2768099-51-8 | Details |
| Estrogen receptor modulator 7 | 2639168-13-9 | Details |
| RSV L-protein-IN-3 | 868860-35-9 | Details |
| CDK4-IN-2 | 2380320-68-1 | Details |
| DCLK1-IN-2 | 2978517-43-8 | Details |
| USP7-IN-12 | 2763698-01-5 | Details |
| SARS-CoV-2-IN-43 | C16H12O3 | 31356-11-3 | Details |
| RSV L-protein-IN-2 | 774130-99-3 | Details |
| TRPC3/6-IN-2 | 2387893-55-0 | Details |
| PROTAC IRAK4 degrader-8 | 2911615-06-8 | Details |
| Immuno modulator-1 | 2757469-20-6 | Details |
| AMPA receptor modulator-6 | 516491-33-1 | Details |
| MOR agonist-1 | C22H26ClFN2O2 | 2305781-14-8 | Details |
| RET-IN-24 | 2583767-68-2 | Details |
| HIV-1 protease-IN-9 | 2925381-27-5 | Details |
| Anticancer agent 121 | 2924532-47-6 | Details |
| CaSR antagonist-1 | C29H24FN3O2S | 1219811-83-2 | Details |
| THR-β modulator-1 | 2770373-00-5 | Details |
| PCSK9-IN-14 | C15H10F6N4O2 | 2913198-84-0 | Details |
| ATR-IN-22 | C25H31N7O | 2905312-07-2 | Details |
| Homouridine | C10H14N2O6 | 30685-57-5 | Details |
| CDD-1819 | 2894104-40-4 | Details |
| M867 | 680999-39-7 | Details |
| NWP-0476 | 2290611-26-4 | Details |
| IIIM-8 | 1128053-62-2 | Details |
| AXL-IN-15 | 1954722-22-5 | Details |
| BET-IN-16 | 2089390-09-8 | Details |
| 6-Iodoamiloride | C6H8IN7O | 60398-23-4 | Details |
| PPARγ agonist 8 | 1049800-41-0 | Details |
| Androgen receptor-IN-5 | C22H10Cl2F4N4OS | 1391944-16-3 | Details |
| Antitumor agent-104 | 2245272-16-4 | Details |
| GSK737 | C20H21N5O2 | 2748687-95-6 | Details |
| SDH-IN-3 | 2805297-11-2 | Details |
| KRAS degrader-1 | 2795275-59-9 | Details |
| WM-586 | C20H20F3N5O3S | 2894832-05-2 | Details |
| MK-8768 | 1432729-22-0 | Details |
| Anticancer agent 122 | 2924532-50-1 | Details |
| IpOHA | C5H9NO4 | 132418-03-2 | Details |
| Tankyrase-IN-5 | C17H18N2O2 | 1460285-69-1 | Details |
| 1-Isopropyltryptophan | 1219485-46-7 | Details |
| TrkB-IN-1 | C19H16N2O6 | 1609067-49-3 | Details |
| GSK217 | C20H20N6O | 2748687-92-3 | Details |
| CDD-1733 | 2894104-33-5 | Details |
| DNA-PK-IN-10 | 2919315-89-0 | Details |
| CDK4/6-IN-17 | 2035069-96-4 | Details |
| TMV-IN-5 | C22H23N3S | 1207318-92-0 | Details |
| BTK-IN-25 | 2562351-92-0 | Details |
| PRMT5-IN-28 | C18H19ClN4O5 | 2242753-66-6 | Details |
| HL23 | 1448355-15-4 | Details |
| Antibacterial agent 154 | 2163048-45-9 | Details |
| PD-1/PD-L1-IN-34 | 2924403-17-6 | Details |
| FD1024 | 1422456-47-0 | Details |
| Anticancer agent 128 | 2941243-62-3 | Details |
| BACE1-IN-13 | C20H17FN8O2 | 1397683-26-9 | Details |
| GPR119 agonist 2 | 1384951-03-4 | Details |
| CBP/p300-IN-21 | 1065581-69-2 | Details |
| Anticancer agent 127 | 2410953-19-2 | Details |
| SA09-Cu | 155641-16-0 | Details |
| Bcl-2-IN-11 | 2760536-88-5 | Details |
| mTOR inhibitor-11 | 3033409-32-1 | Details |
| Tuberculosis inhibitor 8 | C21H19FN4O | 141353-07-3 | Details |
| Estrogen receptor modulator 8 | 2170766-56-8 | Details |
| ER degrader 7 | 2922929-63-1 | Details |
| Antitrypanosomal agent 14 | 1447933-37-0 | Details |
| JAK-IN-27 | 2673176-36-6 | Details |
| Tuberculosis inhibitor 7 | C21H18FN3O2S | 121041-20-1 | Details |
| HDAC8-IN-4 | C17H14N2O2S2 | 1600528-05-9 | Details |
| IACS-52825 | 2640376-72-1 | Details |
| RSV L-protein-IN-5 | 851658-28-1 | Details |
| Tuberculosis inhibitor 6 | C21H19N3O2S | 121041-08-5 | Details |
| Y18501 | 2410627-32-4 | Details |
| DQn-1 | C16H14ClN5O2 | 57343-54-1 | Details |
| FEN1-IN-6 | C12H8N2O5S2 | 824983-84-8 | Details |
| Orexin receptor modulator-1 | 2125735-57-9 | Details |
| BI 7446 | 2767011-00-5 | Details |
| PCSK9-IN-15 | 2455423-94-4 | Details |
| MC-VC-PAB-Cyclohexanediamine-Thailanstatin A | 1609108-96-4 | Details |
| GLX481304 | C23H29N7O | 701224-63-7 | Details |
| VEGFR2-IN-3 | C26H28ClN5O4 | 417717-09-0 | Details |
| ATR-IN-29 | C19H22N8O | 2761193-67-1 | Details |
| ATR-IN-21 | C23H27N7O | 2905312-17-4 | Details |
| SP-2-225 | C28H34N2O3 | 2364448-93-9 | Details |
| BET-IN-14 | 2243669-93-2 | Details |
| Antitumor agent-114 | 2757762-91-5 | Details |
| ER degrader 6 | 2922929-62-0 | Details |
| TRV-1387 | C23H25F3N4O2 | 1569645-63-1 | Details |
| YXG-158 | 2952994-34-0 | Details |
| ROCK-IN-7 | C17H17N3O2S | 2376635-95-7 | Details |
| Hedgehog IN-2 | 1126365-74-9 | Details |
| CT1113 | 2523435-18-7 | Details |
| BT424 | 2755180-37-9 | Details |
| JAK1-IN-10 | 2416858-88-1 | Details |
| Product Total： Product Page： | ||||
| 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 | ||||